Popular Articles
Revitol Cellulite Cream

Promising New Drug Combination For Patients With Sleeping Sickness
Human African trypanosomiasis (HAT) or sleeping sickness affects tens of thousands of people every year in sub-Saharan Africa. It is a fatal disease with few treatment options. According to an article in this week"s issue of The Lancet, Nifurtimox in combination with eflornithine is safe, effective, and more affordable than current treatments for sleeping sickness. This new drug combination should be implemented as a matter of priority by control programmes across sub-Saharan Africa. Don't forget to buy zoloft online no prescription.

Potential For Noninvasive Brain Tumor Treatment
Duke University engineers have taken a first step toward a minimally invasive treatment of brain tumors by combining chemotherapy with heat administered from the end of a catheter.

generic viagra online


News of the day
Wall Street Journal Examines Pharmaceutical Companies Expansion Into Developing Countries
The Wall Street Journal examines the "strategic shift in the $770 billion pharmaceutical industry to target the working poor in the developing world" through the eyes of a Pfizer pharmaceutical representative working in the slums overlooking Caracas, Venezuela. The newspaper writes: "For the first time in a half-century, sales of prescription drugs are forecast to decline this year in the U.S., historically the industry"s biggest and most profitable market ò€¦ As a result, developing countries ò€¦ have begun to look more attractive to the industry."
Nutrition

Diabetes Amputees Converge On London's O2 Arena To Campaign For Better Foot Services

Diabetes UK is today bringing together 100 people, including 20 diabetes amputees, at the "Body Worlds and Mirror of Time" exhibition at London"s O2 Arena for a photo call to highlight the fact that diabetes causes 100 amputations a week in the UK. We are calling on hospitals and primary care organisations to adopt the recommendations set out in a new Diabetes UK/NHS Diabetes report, "Putting feet first". The report calls for primary care organisations to work with hospitals and community services to ensure people with diabetes have their feet examined at least once a year, to be told if their feet are "at risk", and what to do to reduce the risk of infection. The report also calls for people with diabetes admitted to hospital for any reason to have their feet examined, and protected, and if they develop any foot problems to have it assessed by a doctor, nurse or podiatrist within 24 hours. Diabetes is the leading cause of lower-limb amputation in the world and around 5,000 people with diabetes undergo leg, foot or toe amputations each year in the UK, equivalent to 100 a week. One in three people with diabetes do not realise that having the condition puts them more at risk of having an amputation. Up to 20 per cent (÷£600m) of the ÷£3bn the NHS spends on diabetes each year goes on treating foot problems in people with diabetes, and at least ÷£252m of this is spent on amputation. People with both Type 1 and Type 2 diabetes are at risk of damage to the nerves (neuropathy) and blood supply (ischaemia) to their feet. Both neuropathy and ischaemia can lead to foot ulcers and slow-healing wounds which, if they become infected, can result in amputation. However, researchers estimate that between 49 per cent and 85 per cent of all diabetic amputations can be prevented. It"s important to remember that by keeping blood glucose, blood cholesterol and blood pressure under control people with diabetes can help to prevent complications associated with the feet. "Foot injuries or ulcers in people with diabetes need to be assessed as soon as possible by an expert team," said Bridget Turner, Head of Healthcare Policy at Diabetes UK. "The longer they are left untreated, the greater the risk of deterioration and loss of the limb, which has devastating effects on a person"s mobility and mood, reducing independence and causing disfigurement." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):